Nobili V - Search Results

1

Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).

Nobili V, Mosca A, Alterio T, Cardile S, Putignani L. Nobili V, et al. Adv Exp Med Biol. 2019;1125:85-100. doi: 10.1007/5584_2018_318. Adv Exp Med Biol. 2019. PMID: 30578461 Review.

2

Pediatric NAFLD: the Future role of Patient-Tailored Probiotics Therapy.

Putignani L, Alisi A, Nobili V. Putignani L, et al. Among authors: nobili v. J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S6-8. doi: 10.1097/MPG.0000000000001220. J Pediatr Gastroenterol Nutr. 2016. PMID: 27380600 Review.

3

Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.

Mann JP, De Vito R, Mosca A, Alisi A, Armstrong MJ, Raponi M, Baumann U, Nobili V. Mann JP, et al. Among authors: nobili v. Hepatology. 2016 Mar;63(3):745-53. doi: 10.1002/hep.28374. Epub 2016 Jan 14. Hepatology. 2016. PMID: 26638195

4

Pediatric liver diseases: current challenges and future perspectives.

Della Corte C, Mosca A, Vania A, Alterio A, Alisi A, Nobili V. Della Corte C, et al. Among authors: nobili v. Expert Rev Gastroenterol Hepatol. 2016;10(2):255-65. doi: 10.1586/17474124.2016.1129274. Epub 2015 Dec 27. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26641319 Review.

5

Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.

Del Chierico F, Nobili V, Vernocchi P, Russo A, De Stefanis C, Gnani D, Furlanello C, Zandonà A, Paci P, Capuani G, Dallapiccola B, Miccheli A, Alisi A, Putignani L. Del Chierico F, et al. Among authors: nobili v. Hepatology. 2017 Feb;65(2):451-464. doi: 10.1002/hep.28572. Epub 2016 Jun 2. Hepatology. 2017. PMID: 27028797

6

Beverage consumption and paediatric NAFLD.

Mosca A, Della Corte C, Sartorelli MR, Ferretti F, Nicita F, Vania A, Nobili V. Mosca A, et al. Among authors: nobili v. Eat Weight Disord. 2016 Dec;21(4):581-588. doi: 10.1007/s40519-016-0315-3. Epub 2016 Aug 26. Eat Weight Disord. 2016. PMID: 27565159 Review.

7

Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.

Mosca A, Comparcola D, Romito I, Mantovani A, Nobili V, Byrne CD, Alisi A, Targher G. Mosca A, et al. Among authors: nobili v. Liver Int. 2019 Dec;39(12):2317-2329. doi: 10.1111/liv.14225. Epub 2019 Sep 10. Liver Int. 2019. PMID: 31436362

8

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.

Mosca A, Nobili V, De Vito R, Crudele A, Scorletti E, Villani A, Alisi A, Byrne CD. Mosca A, et al. Among authors: nobili v. J Hepatol. 2017 May;66(5):1031-1036. doi: 10.1016/j.jhep.2016.12.025. Epub 2017 Feb 14. J Hepatol. 2017. PMID: 28214020

9

Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study.

Della Corte C, Mosca A, Vania A, Alterio A, Iasevoli S, Nobili V. Della Corte C, et al. Among authors: nobili v. Nutrition. 2017 Jul-Aug;39-40:8-14. doi: 10.1016/j.nut.2017.02.008. Epub 2017 Feb 27. Nutrition. 2017. PMID: 28606575

10

Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.

Giorgio V, Mosca A, Alterio A, Alisi A, Grieco A, Nobili V, Miele L. Giorgio V, et al. Among authors: nobili v. J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):150-155. doi: 10.1097/MPG.0000000000001614. J Pediatr Gastroenterol Nutr. 2017. PMID: 28737569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page